Dow Down 0.02% Nasdaq Up 0.07%

Ligand Pharmaceuticals Incorporated (LGND)

-NasdaqGM
53.99 Down 0.09(0.17%) 4:00PM EST
|After Hours : 53.98 Down 0.01 (0.01%) 4:35PM EST
Prev Close:54.08
Open:54.09
Bid:53.18 x 100
Ask:57.89 x 100
1y Target Est:87.50
Beta:2.04
Earnings Date:Feb 9 - Feb 13 (Est.)
Day's Range:53.61 - 54.77
52wk Range:41.99 - 80.42
Volume:205,660
Avg Vol (3m):390,352
Market Cap:1.08B
P/E (ttm):163.61
EPS (ttm):0.33
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
LGNDDown 0.17%1.08B
LLYDown 0.12%71.50B
MRKUp 0.15%169.17B
RHHBYDown 0.37%252.84B

Key Statistics

Forward P/E (1 yr):23.07
P/S (ttm):19.24
Ex-Dividend Date:02-Jul-10

Analysts

Annual EPS Est (Dec-14) :1.53
Quarterly EPS Est (Dec-14) :0.61
Mean Recommendation*:2.3
PEG Ratio (5 yr expected):1.18

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Ligand Pharmaceuticals Incorporated, a biotechnology company, acquires and develops royalty revenue generating assets in the United States. Its late-stage development programs include Promacta, an oral thrombopoietin receptor agonist therapy for t... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback